GGrantIndex
Sort

78,016 grants matching breast cancer

Biomarkers for predicting response to Hsp90 therapy

$599,324
Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA

Tissue Array Research Program

$599,322
Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer

$599,304
Gokul M Das · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA

The Symptom Experience, Management and Outcomes According to Race and Social Determinants of Health (SEMOARS) during Breast Cancer Chemotherapy

$599,261
Margaret Q Rosenzweig · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · MD

Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci

$599,202
Simon Andrew Gayther · University Of Texas Hlth Science Center · R01 · FY2024 · CA

Determinants of genetic penetrance in identical twins with breast cancer

$599,198
Thomas McCulloch Mack · University Of Southern California · R01 · FY2018 · CA

Luteal adjuvant oophorectomy in asian breast cancer

$599,186
Richard Reed Love · Ohio State University · R01 · FY2010 · CA

Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis

$599,174
Yuanpei Li · University Of California At Davis · R01 · FY2025 · EB

Small Animal Irradiator with Cone Beam CT

$599,155
Ross B Mikkelsen · Virginia Commonwealth University · S10 · FY2011 · RR

Philadelphia Breast Cancer Family Registry

$599,114
Mary Beryl Daly · Fox Chase Cancer Center · U01 · FY2006 · CA

Reducing disparities in colorectal cancer screening in Vietnamese Americans

$599,078
Bang H Nguyen · Cancer Prevention Instit Of California · R01 · FY2008 · CA

Leica TCS SP5 MP confocal and two-photon microscope

$599,068
Martin D Brand · Buck Institute For Research On Aging · S10 · FY2012 · OD

Antioxidant supplements, genetics and chemotherapy outcomes

$599,028
Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2007 · CA

Regulators of Cancer Immunotherapy Response

$598,991
Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Role of tumor heterogeneity on receptor engagement

$598,957
Xavier Intes · Rensselaer Polytechnic Institute · R01 · FY2021 · CA

Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer

$598,928
Lorenzo Sempere · Michigan State University · R01 · FY2022 · CA

Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response

$598,918
Anna Moore · Massachusetts General Hospital · R01 · FY2009 · CA

Epigenetic and metabolic bottlenecks of tumorigenesis

$598,888
Ana Da Silva Gomes · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

Clinical Translation of High Energy Phase-Sensitive X-ray Breast Tomosynthesis

$598,822
Hong Liu · University Of Oklahoma · R01 · FY2015 · CA

Hormonal Regulation of Breast Cancer

$598,799
Jeffrey Rosen · Baylor College Of Medicine · R01 · FY2019 · CA

Role of tumor heterogeneity on receptor engagement

$598,768
Xavier Intes · Rensselaer Polytechnic Institute · R01 · FY2018 · CA

Computerized histologic image predictor of cancer outcome

$598,709
Hannah Gilmore · Case Western Reserve University · R01 · FY2020 · CA

NCI X-ray free electron laser (XFEL) initiative

$598,705
Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Determinants of Breast Cancer Survival

$598,685
University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA

Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms

$598,671
Mohamad Imad Damaj · Virginia Commonwealth University · R01 · FY2024 · CA